Janssen Announces U.S. FDA Approval of CABENUVA (rilpivirine and cabotegravir), the First Long-Acting Regimen for the Treatment of HIV
TITUSVILLE, N.J., January 21, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced the U.S. Food and Drug Administration (FDA) has approved CABENUVA (consisting of Janssen’s rilpivirine and ViiV Healthcare’s cabotegravir), the first and only once-monthly, long-acting regimen for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults. The novel regimen was co-developed as part of a collaboration with ViiV Healthcare and builds on Janssen’s 25-year commitment to make HIV history. In the U.S., ViiV Healthcare is the marketing authorization holde...
Source: Johnson and Johnson - January 22, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

A Swiss money-laundering probe raises disturbing questions
We investigate the uncomfortably close links between the Swiss and Russian authorities in the Magnitsky case (Source: Reuters: Health)
Source: Reuters: Health - January 21, 2021 Category: Consumer Health News Source Type: news

FDA grants priority review to Roche ’s Esbriet (pirfenidone) for unclassifiable interstitial lung disease
Basel, 21 January 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the US Food and Drug Administration (FDA) has accepted the company ’s supplemental New Drug Application (sNDA) and granted Priority Review for Esbriet® (pirfenidone) for the treatment of unclassifiable interstitial lung disease (UILD). The FDA is expected to make a decision on approval by May 2021.“Since its US approval, Esbriet has become a standard of care for people living with idiopathic pulmonary fibrosis. However, significant unmet need remains in fibrotic lung diseases, including unclassifiable interstitial lung disease ...
Source: Roche Investor Update - January 21, 2021 Category: Pharmaceuticals Source Type: news

Occlutech's Atrial Flow Regulator (AFR) Receives U.S. FDA Breakthrough Device Designation for Heart Failure (HF)
SCHAFFHAUSEN, Switzerland, Jan. 19, 2021 -- (Healthcare Sales & Marketing Network) -- Occlutech, a privately-held company, announced today that the U.S Food and Drug Administration (FDA) has granted the Company a Breakthrough Device designation for its fi... Devices, Cardiology, FDA Occlutech, Atrial Flow Regulator, heart failure (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 19, 2021 Category: Pharmaceuticals Source Type: news

The Latest: Swiss quarantine 2 hotels over new virus variant
Swiss authorities say they have placed two hotels under quarantine and ordered that all guests and employees be tested after a new variant of the coronavirus was detected among them in the upscale skiing resort of St. Moritz (Source: ABC News: Health)
Source: ABC News: Health - January 18, 2021 Category: Consumer Health News Tags: Health Source Type: news

Roche Annual General Meeting 2021: Exercising of shareholder rights via the independent proxy
Basel, 18 January 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that unfortunately it will not be possible for shareholders to attend the Annual General Meeting in person owing to the ongoing pandemic. Our main concern is to protect our shareholders from any potential health risks that may arise because of the ongoing difficult pandemic situation. As a precautionary and prudent measure, the Board of Directors has decided to conduct the Annual General Meeting of Roche Holding Ltd on Tuesday, 16 March 2021, in accordance with Art. 8 of the Federal Act on the Statutory Principles for Federal Council Ordinances on ...
Source: Roche Media News - January 18, 2021 Category: Pharmaceuticals Source Type: news

Roche Annual General Meeting 2021: Exercising of shareholder rights via the independent proxy
Basel, 18 January 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that unfortunately it will not be possible for shareholders to attend the Annual General Meeting in person owing to the ongoing pandemic. Our main concern is to protect our shareholders from any potential health risks that may arise because of the ongoing difficult pandemic situation. As a precautionary and prudent measure, the Board of Directors has decided to conduct the Annual General Meeting of Roche Holding Ltd on Tuesday, 16 March 2021, in accordance with Art. 8 of the Federal Act on the Statutory Principles for Federal Council Ordinances on ...
Source: Roche Investor Update - January 18, 2021 Category: Pharmaceuticals Source Type: news

Switzerland is holding a referendum on whether to strip the government of its power to impose coronavirus lockdowns
The referendum comes amid an increasing national debate in Switzerland about the rights of individuals. (Source: Reuters: Health)
Source: Reuters: Health - January 14, 2021 Category: Consumer Health News Source Type: news

New Hampshire Still Deciding On Expanding COVID Vaccine Eligibility To Those 65 And Older
cbsoptanon.onScriptsReady(function(cmp){cmp.ot.targetingAllowed(function(a){if(a) AnvatoPlayer("p0").init({"mcp":"cbs","width":"100%","height":"100%","video":"5192570","autoplay":false,"titleVisible":false,"accessKey":"EZqvRyKE7qmqDflDPXIw6U7kKZEA0Vx7","accessControl":{"preview":false},"pInstance":"p0","plugins":{"heartbeat":{"account":"cbslocal-global-unified","publisherId":"cbslocal","jobId...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - January 13, 2021 Category: Consumer Health News Authors: Health – CBS Boston Tags: Boston News Health Syndicated CBSN Boston Coronavirus Coronavirus Vaccine New Hampshire News Source Type: news

Inferring human genomes at a fraction of the cost promises to boost biomedical research
(Swiss Institute of Bioinformatics) A new method, developed by Olivier Delaneau's group at the SIB Swiss Institute of Bioinformatics and the University of Lausanne, offers game-changing possibilities for genetic association studies and biomedical research. For less than $1 in computational cost, GLIMPSE is able to statistically infer a complete human genome from a very small amount of data. It offers a first realistic alternative to current approaches, and so allows a wider inclusion of underrepresented populations. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 13, 2021 Category: International Medicine & Public Health Source Type: news

Are changes in personality traits and alcohol use associated? A cohort study among young Swiss men - Gmel G, Marmet S, Studer J, Wicki M.
OBJECTIVE: It is well known that certain personality traits are associated with alcohol use. Because less is known about it, we wished to investigate whether changes in alcohol use were longitudinally associated with changes in personality and in which dir... (Source: SafetyLit)
Source: SafetyLit - January 13, 2021 Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news

The Beirut blast 2020: lessons learned from the Swiss Emergency Medical Team specialized "Mother & Child" - Hagon O, Dumont L.
On August 4, 2020, Beirut was hit by a devastating explosion leading to mass casualties: thousands were injured and there were significant damages to residences, offices, and health structures. The Emergency Medical Team (EMT) specialized "Mother and Child... (Source: SafetyLit)
Source: SafetyLit - January 13, 2021 Category: International Medicine & Public Health Tags: Burns, Electricity, Explosions, Fire, Scalds Source Type: news

Access Consortium statement on COVID-19 vaccines evidence, MHRA (published 7th January 2021)
This collective statement from medicine regulators from Australia, Canada, Singapore, Switzerland and the UK discusses the regulatory evidence requirements for COVID-19 vaccine approvals and considerations for post-market pharmacovigilance. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - January 11, 2021 Category: Consumer Health News Source Type: news

mRNA Technology Gave Us the First COVID-19 Vaccines. It Could Also Upend the Drug Industry
“No!” The doctor snapped. “Look at me!” I had been staring her in the eyes, as she had ordered, but when a doctor on my other side began jabbing me with a needle, I started to turn my head. “Don’t look at it,” the first doctor said. I obeyed. This was in early August in New Orleans, where I had signed up to be a participant in the clinical trial for the Pfizer-BioNTech COVID-19 vaccine. It was a blind study, which meant I was not supposed to know whether I had gotten the placebo or the real vaccine. I asked the doctor if I would really been able to tell by looking at the syringe. &...
Source: TIME: Health - January 11, 2021 Category: Consumer Health News Authors: Walter Isaacson Tags: Uncategorized COVID-19 feature Magazine Source Type: news

mRNA Technology Gave Us the First COVID-19 Vaccines. It Could Also Upend the Drug Industry
“No!” The doctor snapped. “Look at me!” I had been staring her in the eyes, as she had ordered, but when a doctor on my other side began jabbing me with a needle, I started to turn my head. “Don’t look at it,” the first doctor said. I obeyed. This was in early August in New Orleans, where I had signed up to be a participant in the clinical trial for the Pfizer-BioNTech COVID-19 vaccine. It was a blind study, which meant I was not supposed to know whether I had gotten the placebo or the real vaccine. I asked the doctor if I would really been able to tell by looking at the syringe. &...
Source: TIME: Science - January 11, 2021 Category: Science Authors: Walter Isaacson Tags: Uncategorized COVID-19 feature Magazine Source Type: news

'Swiss Army knife' catalyst can make natural gas burn cleaner
(University of Illinois at Chicago) 'Swiss Army knife' catalyst can bring the combustion temperature of methane down by about half - from above 1400 degrees Kelvin down to 600 to 700 degrees Kelvin. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - January 11, 2021 Category: Biology Source Type: news

Italian government implicated in elaborate election fraud scheme against Trump
(Natural News) Swiss-American author and researcher Neal Sutz has revealed that not just Switzerland but also Italy played a major role in stealing the 2020 election for Joe Biden. Switzerland, Sutz revealed, recently purchased the sole rights of Scytl, the bankrupt Spanish company tied to Dominion Voting Systems that, according to several statistical analyses, switched... (Source: NaturalNews.com)
Source: NaturalNews.com - January 8, 2021 Category: Consumer Health News Source Type: news

Food for thought? French bean plants show signs of intent, say scientists
Many botanists dispute idea of plant sentience, but study of climbing beans sows seed of doubtThey ’ve provided us with companionship and purpose during the darkest days of lockdown, not to mention brightening our Instagram feeds. But the potted cacti, yucca, and swiss cheese plants we’ve welcomed into our homes are entirely passive houseguests. Aren’t they?Research suggests that at least one type of plant – the french bean – may be more sentient than we give it credit for: namely, it may possess intent.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - January 8, 2021 Category: Science Authors: Linda Geddes Science correspondent Tags: Plants Environment Science Biology Source Type: news

Risk related to spread of new SARSCoV-2 variants of concern in the EU/EEA, ECDC
New variants of current concern: The United Kingdom (UK) has faced a rapid increase in COVID-19 case rates in the South-East, the East and the London area, which is associated with the emergence of a new SARS-CoV-2 variant, VOC 202012/01. As of 26 December 2020, more than 3 000 cases of this new variant, confirmed by genome sequencing, have been reported from the UK. An increasing proportion of cases in the South East, the East and the London area are due to this variant, but cases have also been identified in other parts of the UK. Although it was first reported in early December, the initial cases were retrospectively id...
Source: Current Awareness Service for Health (CASH) - January 7, 2021 Category: Consumer Health News Source Type: news

Mouse study finds link between gut disease and brain injury in premature infants
(Johns Hopkins Medicine) Working with mice, researchers at Johns Hopkins Medicine and the University of Lausanne in Switzerland have identified an immune system cell that they say travels from the gut to the brain and attacks cells rather than protect them as it normally does. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 6, 2021 Category: International Medicine & Public Health Source Type: news

Swiss startup OnlineDoctor completes €5M Series A funding
The company will use the funding to expand its teledermatology services and 600 specialists in the DACH region. (Source: mobihealthnews)
Source: mobihealthnews - January 5, 2021 Category: Information Technology Source Type: news

Invitation to Roche ’s Full Year Results 2020 Presentation
Roche will publish its Full Year Results for 2020 prior to the opening of the Swiss Stock Exchange on Thursday, 4 February 2021. (Source: Roche Investor Update)
Source: Roche Investor Update - January 5, 2021 Category: Pharmaceuticals Source Type: news

Italy’s Angelini to buy Swiss biotech group for $1bn
Pharma group to get exclusive licence to commercialise epilepsy drug across EU, UK and Switzerland (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - January 3, 2021 Category: Pharmaceuticals Source Type: news

Performance of self-reported measures of alcohol use and of harmful drinking patterns against ethyl glucuronide hair testing among young Swiss men - Iglesias K, Lannoy S, Sporkert F, Daeppen JB, Gmel G, Baggio S.
BACKGROUND: There is a need for empirical studies assessing the psychometric properties of self-reported alcohol use as measures of excessive chronic drinking (ECD) compared to those of objective measures, such as ethyl glucuronide (EtG). OBJECTI... (Source: SafetyLit)
Source: SafetyLit - December 31, 2020 Category: International Medicine & Public Health Tags: Alcohol and Other Drugs Source Type: news

Oxygen Desaturation Common in Babies With Acute Bronchiolitis Oxygen Desaturation Common in Babies With Acute Bronchiolitis
Oxygen desaturation is common in infants with acute bronchiolitis, especially in those who present with more severe initial illness, researchers from Switzerland report.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - December 30, 2020 Category: Consumer Health News Tags: Pediatrics News Source Type: news

Tram, rail, bicycle: an unhappy triad? Rising incidence and resource consumption of tramline-associated bicycling accidents in Bern, Switzerland - Gerber JL, Suppiger T, Sauter TC, Traschitzger M, Muller M, Exadaktylos AK.
Bicycle traffic and the number of accidents have been increasing in Switzerland in recent years. However, little is known about specific types of bicycling accidents - such as tramline-associated bicycling accidents (TABA) - that are potentially avoidab... (Source: SafetyLit)
Source: SafetyLit - December 30, 2020 Category: International Medicine & Public Health Tags: Engineering, Physics, Structural Soundness and Failure Source Type: news

Distalmotion Receives European CE Mark for Dexter Surgical Robot
Dexter ready for clinical use CE Mark follows validation of Dexter clinical benefits by surgeons and nurses from leading European hospitals, across urology, gynaecology and general surgery earlier this year LAUSANNE, Switzerland, Dec. 29, 2020 -- (He... Devices, Surgery, Regulatory Distalmotion, Dexter, robotic surgery (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - December 29, 2020 Category: Pharmaceuticals Source Type: news

British tourists 'fled' Swiss ski resort quarantine
British tourists fled the Swiss ski resort of Verbier "clandestinely" under cover of darkness rather than submit to a new quarantine... (Source: Reuters: Health)
Source: Reuters: Health - December 28, 2020 Category: Consumer Health News Source Type: news

More than 200 British skiers flee Swiss Verbier quarantine. This comes as the Swiss health ministry said on Sunday two cases of the...
More than 200 Britons flee Verbier, defying a Swiss order to remain in their hotels and chalets. (Source: Reuters: Health)
Source: Reuters: Health - December 28, 2020 Category: Consumer Health News Source Type: news

Scientists call for UK lockdown after rapid spread of Covid-19 variant
Stricter measures needed as cases of mutated virus, linked to UK travellers, are reported across globeCoronavirus – latest updatesSee all our coronavirus coverageCases of the new variant Covid-19 virus were confirmed in several European countries on Saturday, including Spain, Sweden and Switzerland. All were linked to people who had arrived from the UK.Meanwhile, Japan has announced it is banning all new entries of foreign nationals from Monday following the discovery of the variant in travellers from the UK.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - December 27, 2020 Category: Science Authors: Robin McKie, Toby Helm and Jamie Doward Tags: Coronavirus Infectious diseases World news Microbiology Medical research Science Source Type: news

FDA Approves Gemtesa (vibegron) Tablets for the Treatment of Patients with Overactive Bladder (OAB)
IRVINE, Calif.& BASEL, Switzerland--(BUSINESS WIRE)--Dec. 23, 2020-- Urovant Sciences (Nasdaq: UROV) announced today that the U.S. Food and Drug Administration (FDA) has approved the New Drug Application (NDA) for once-daily 75 mg Gemtesa... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - December 23, 2020 Category: Drugs & Pharmacology Source Type: news

European Commission approves Roche ’s Phesgo (fixed-dose combination of Perjeta and Herceptin for subcutaneous injection) for people with HER2-positive breast cancer
Basel, 23 December 2020 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the European Commission has approved Phesgo®, a fixed-dose combination of Perjeta® (pertuzumab) and Herceptin® (trastuzumab) with hyaluronidase, administered by subcutaneous (SC; under the skin) injection for the treatment of early and metastatic HER2-positive breast cancer.“This approval represents a significant step forward in the treatment of HER2-positive breast cancer,” said Levi Garraway, M.D., Ph.D., Roche’s Chief Medical Officer and Head of Global Product Development. “The innovation of Phesgo...
Source: Roche Media News - December 23, 2020 Category: Pharmaceuticals Source Type: news

European Commission approves Roche ’s Phesgo (fixed-dose combination of Perjeta and Herceptin for subcutaneous injection) for people with HER2-positive breast cancer
Basel, 23 December 2020 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the European Commission has approved Phesgo®, a fixed-dose combination of Perjeta® (pertuzumab) and Herceptin® (trastuzumab) with hyaluronidase, administered by subcutaneous (SC; under the skin) injection for the treatment of early and metastatic HER2-positive breast cancer.“This approval represents a significant step forward in the treatment of HER2-positive breast cancer,” said Levi Garraway, M.D., Ph.D., Roche’s Chief Medical Officer and Head of Global Product Development. “The innovation of Phesgo...
Source: Roche Investor Update - December 23, 2020 Category: Pharmaceuticals Source Type: news

Glenmark inks pact with Menarini Group to commercialise nasal spray in Europe
Glenmark Specialty, a Switzerland-based unit of the company, has entered into an exclusive licensing agreement with the Menarini Group for Ryaltris, the Mumbai-based drug firm said in a statement. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 23, 2020 Category: Pharmaceuticals Source Type: news

Emergency room and major trauma treatment is a  "loss-making business" : a Swiss trauma center experience with current DRG reimbursement - Gross T, Amsler F.
BACKGROUND: The study objective was to find out how cost-covering the treatment of patients with a  potentially severe injury actually is in a Swiss trauma center and to what extent hospital profits/losses correlate with patient-related accident, treatmen... (Source: SafetyLit)
Source: SafetyLit - December 21, 2020 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news

European Union Greenlights BioNTech-Pfizer COVID-19 Vaccine After Agency Gives Safety Approval
(AMSTERDAM) — The European Union on Monday gave official approval for the coronavirus vaccine developed by BioNTech and Pfizer to be used across the 27-nation bloc, raising hopes that countries can begin administering the first shots to their citizens shortly after Christmas. The EU’s executive commission gave the green light just hours after the European Medicines Agency said the vaccine meets safety and quality standards. Brussels had been expected to take two or three days to endorse the market authorization move. “As we have promised, this vaccine will be available for all EU countries at the same tim...
Source: TIME: Health - December 21, 2020 Category: Consumer Health News Authors: ALEKSANDAR FURTULA and FRANK JORDANS / AP Tags: Uncategorized COVID-19 wire Source Type: news

Roche ’s faricimab meets primary endpoint and shows strong durability across two global phase III studies for diabetic macular edema, a leading cause of blindness
Basel, 21 December 2020 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced positive topline results from two identically designed global phase III studies, YOSEMITE and RHINE, evaluating its investigational bispecific antibody, faricimab, in people living with diabetic macular edema (DME). Both studies met their primary endpoint and showed that faricimab given every eight weeks and at personalised dosing intervals of up to 16 weeks demonstrated non-inferior visual acuity gains compared to aflibercept given every eight weeks. Faricimab was generally well-tolerated, with no new safety signals identified. The studies each h...
Source: Roche Media News - December 21, 2020 Category: Pharmaceuticals Source Type: news

Roche ’s faricimab meets primary endpoint and shows strong durability across two global phase III studies for diabetic macular edema, a leading cause of blindness
Basel, 21 December 2020 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced positive topline results from two identically designed global phase III studies, YOSEMITE and RHINE, evaluating its investigational bispecific antibody, faricimab, in people living with diabetic macular edema (DME). Both studies met their primary endpoint and showed that faricimab given every eight weeks and at personalised dosing intervals of up to 16 weeks demonstrated non-inferior visual acuity gains compared to aflibercept given every eight weeks. Faricimab was generally well-tolerated, with no new safety signals identified. The studies each h...
Source: Roche Investor Update - December 21, 2020 Category: Pharmaceuticals Source Type: news

Switzerland OKs Pfizer-BioNTech vaccine
U.S. health officials closely tracking possible side effects of the first authorized COVID-19 vaccine say they have seen six cases of severe allergic reaction out of more than a quarter million shots given (Source: ABC News: Health)
Source: ABC News: Health - December 19, 2020 Category: Consumer Health News Tags: Health Source Type: news

Coronavirus live news: UK cabinet to hold meeting amid fears over new virus strain; Swiss approve Pfizer vaccine
Italy and Australia announce new lockdowns; France death toll surpasses 60,000; Sweden introduces tough new measuresNew strain in south-east England prompts fears of third lockdownCovid cases in India reach 10m as country plans vaccination programmeItaly to go into Covid lockdown over festive periodMike Pence receives Covid-19 vaccine on live TV: ‘I didn’t feel a thing’Unions say mass testing of England ’s pupils ‘undeliverable’12.47pmGMTAt least nine coronavirus patients have died after an oxygen tank explosion triggered a fire at a hospital in southeasternTurkey, according to AFP.The b...
Source: Guardian Unlimited Science - December 19, 2020 Category: Science Authors: Damien Gayle (now), Lisa Cox , Elias Visontay and Josh Taylor (earlier) Tags: World news Coronavirus Infectious diseases Science Source Type: news

FDA Approves Orgovyx (relugolix) as the First Oral Gonadotropin-Releasing Hormone (GnRH) Receptor Antagonist for Advanced Prostate Cancer
BASEL, Switzerland, Dec. 18, 2020 (GLOBE NEWSWIRE) -- Myovant Sciences (NYSE: MYOV), a healthcare company focused on redefining care for women and for men, today announced that the U.S. Food and Drug Administration (FDA) has approved Orgovyx... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - December 18, 2020 Category: Drugs & Pharmacology Source Type: news

Swiss to shut restaurants, other sites as virus cases climb
The Swiss government says it's ordering shut restaurants, bars, cultural venues and sports facilities next week as the Alpine country grapples with an ongoing rise in coronavirus cases (Source: ABC News: Health)
Source: ABC News: Health - December 18, 2020 Category: Consumer Health News Tags: Health Source Type: news

Occlutech's Atrial Flow Regulator (AFR) Receives U.S. FDA Breakthrough Device Designation
SCHAFFHAUSEN, Switzerland, Dec. 18, 2020 -- (Healthcare Sales & Marketing Network) -- Occlutech, a privately-held company, announced today that the US Food and Drug Administration (FDA) has granted the company a Breakthrough Device designation for its fir... Devices, Interventional, Cardiology, FDA Occlutech, Atrial Flow Regulator, Pulmonary Arterial Hypertension (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - December 18, 2020 Category: Pharmaceuticals Source Type: news

Income-related inequalities in affordability and access to primary care in eleven high-income countries
To compare the health experiences of adults with a lower income during the pandemic and the effect of income-related disparities, the Commonwealth Fund surveyed adults across 11 high-income countries: Australia, Canada, France, Germany, the Netherlands, New Zealand, Norway, Sweden, Switzerland, the United Kingdom, and the United States. In nearly all countries, adults with a lower income were significantly more likely than those with a higher income to have multiple chronic health conditions. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - December 18, 2020 Category: Consumer Health News Source Type: news

How climate change is disrupting ecosystems
(ETH Zurich) When it gets warmer, organisms rise higher from the lowlands. Swiss Researchers investigated what could happen to plant communities on alpine grasslands if grasshoppers from lower elevations settled there. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - December 17, 2020 Category: Biology Source Type: news

icotec ag Partners with G-21 to Provide Combined Bone Cement and Delivery Solution for Pedicle Screw Augmentation Procedures
ALTSTAETTEN, Switzerland, Dec. 16, 2020 -- (Healthcare Sales & Marketing Network) -- icotec ag, a leading medical device manufacturer of Carbon/PEEK implants, strategically corporates with G-21 to distribute their bone cements in conjunction with icotec's... Devices, Orthopaedic, Neurosurgery, Distribution icotec, VADER, Pedicle System, pedicle screw, spine surgery (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - December 16, 2020 Category: Pharmaceuticals Source Type: news

Cochrane Germany vs. COVID-19: Working together to share research evidence
During the COVID-19 pandemic,Cochrane Germany wanted to build partnerships to share the best available evidence with as many people as possible, and make the findings from Cochrane systematic reviews accessible to German-speaking audiences.Cochrane achieved their goals in several ways.   They highlighted evidence and resources on their website and developed COVID-19 related blogs in partnership withCochrane Switzerland andCochrane Austria. They disseminated COVID-19 press releases to journalists, and partnered with the associated Institute of Evidence in Medicine (IfEM) at the Medical Center - University of Freiburg t...
Source: Cochrane News and Events - December 16, 2020 Category: Information Technology Authors: Lydia Parsonson Source Type: news

Refined dry-snow avalanche danger ratings in regional avalanche forecasts: Consistent? And better than random? - Techel F, Pielmeier C, Winkler K.
In public avalanche forecasts, avalanche danger is summarized using a five-level ordinal danger scale. However, in Switzerland - but also in other countries - on about 75% of the forecasting days, only two of the five danger levels are actually used, indic... (Source: SafetyLit)
Source: SafetyLit - December 16, 2020 Category: International Medicine & Public Health Tags: Disaster Preparedness Source Type: news

Plantwatch: holly, ivy and how warmer weather boosts Christmas plants
These evergreens are thriving due to climate change but can smother other woodland speciesThe holly and ivy decorations should be looking lush this Christmas thanks to climate change boosting the growth of these plants.In a study 15 years ago, holly was found spreading further north in Europe than ever before. The plant had pushed northwards by 80 miles (130km) in more than 60 years and was seen in Norway and Sweden where it was being used forChristmas decorations for the first time.Ivy is also becoming more widespread across forests in Europe. In just over 80 years it has spread across more areas of forests, withrising te...
Source: Guardian Unlimited Science - December 16, 2020 Category: Science Authors: Paul Simons Tags: Science Climate change Environment Trees and forests Source Type: news

Intellectual Property Monopolies Block Vaccine Access
By Anis Chowdhury and Jomo Kwame SundaramSYDNEY and KUALA LUMPUR, Dec 15 2020 (IPS) Just before the World Health Assembly (WHA), an 18 May open letter by world leaders and experts urged governments to ensure that all COVID-19 vaccines, treatments and tests are patent-free, fairly distributed and available to all, free of charge. Pious promises Leaders of Italy, France, Germany, Norway and the European Commission called for the vaccine to be “produced by the world, for the whole world” as a “global public good of the 21st century”, while China’s President Xi promised a vaccine developed by Chi...
Source: IPS Inter Press Service - Health - December 15, 2020 Category: International Medicine & Public Health Authors: Anis Chowdhury and Jomo Kwame Sundaram Tags: Civil Society Development & Aid Economy & Trade Featured Global Headlines Health Human Rights Humanitarian Emergencies Poverty & SDGs TerraViva United Nations Jomo Kwame Sundaram & Anis Chowdhury Source Type: news